REDWOOD CITY, Calif. - Rezolute, Inc. (NASDAQ:RZLT) announced outcomes from a meeting with the U.S. Food and Drug Administration held on March 17 regarding its Phase 3 sunRIZE trial of ersodetug for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results